These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 12422644

  • 1. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB, Semenova OV, Bogadel'nikova IV, Kunichan AD, Zeliger LR, Elistratova NA.
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [Abstract] [Full Text] [Related]

  • 2. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA.
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [Abstract] [Full Text] [Related]

  • 3. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 4. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 5. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 6. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB, Koriakin VA, Khalbaeva IV, Elistratova NA, Ziia AV.
    Probl Tuberk; 1993 Mar 11; (5):21-3. PubMed ID: 8295879
    [Abstract] [Full Text] [Related]

  • 7. Relapse rates in tuberculosis patients.
    de Villiers CL, Macnab MF.
    S Afr Med J; 1995 Feb 11; 85(2):114-5. PubMed ID: 7597522
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of tuberculosis].
    Ben Amar J, Dhahri B, Aouina H, Azzabi S, Baccar MA, El Gharbi L, Bouacha H.
    Rev Pneumol Clin; 2015 Feb 11; 71(2-3):122-9. PubMed ID: 25434510
    [Abstract] [Full Text] [Related]

  • 9. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
    Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M, PanACEA consortium.
    Lancet Infect Dis; 2017 Jan 11; 17(1):39-49. PubMed ID: 28100438
    [Abstract] [Full Text] [Related]

  • 10. [Current treatment of pulmonary tuberculosis].
    Bollinelli R.
    Presse Med; 1984 Jun 02; 13(23):1427-9. PubMed ID: 6233587
    [No Abstract] [Full Text] [Related]

  • 11. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S.
    Rev Clin Esp; 1972 May 31; 125(4):353-6. PubMed ID: 5080180
    [No Abstract] [Full Text] [Related]

  • 12. [Tuberculosis treatment today].
    Sjögren I, Boman G, Löfdahl CG, Skoogh BE.
    Lakartidningen; 1984 Dec 05; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy for tuberculosis today.
    Stead WW, Dutt AK.
    Am Rev Respir Dis; 1982 Mar 05; 125(3 Pt 2):94-101. PubMed ID: 7041725
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P, Baghaei P, Hemmati N, Mirsaeidi M, Kazempour M, Mansouri D, Masjedi MR.
    East Mediterr Health J; 2009 Mar 05; 15(6):1346-50. PubMed ID: 20218123
    [Abstract] [Full Text] [Related]

  • 16. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S, Silva I, Leiria-Pinto P, Rosado-Pinto J.
    Allergol Immunopathol (Madr); 2009 Mar 05; 37(6):336-8. PubMed ID: 19875222
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
    Babalik A, Ulus IH, Bakirci N, Kuyucu T, Arpag H, Dagyildizi L, Capaner E.
    Antimicrob Agents Chemother; 2013 Nov 05; 57(11):5740-2. PubMed ID: 23979746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP, Ebrahim S, Pillay V.
    Int J Tuberc Lung Dis; 2003 Mar 05; 7(3):289-97. PubMed ID: 12661846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.